Atrial Fibrillation in Cancer Patients: Who is at Risk?
Cancer is the second leading cause of mortality in the world, second only to cardiovascular diseases. Simultaneously cancer mortality has been steadily decreasing due to the development of new chemotherapy and targeted drugs and the improvement of existing treatment protocols. Improving the pr...
Saved in:
Main Authors: | Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atrial fibrillation in a patient with lung cancer: a case report
by: E. Yu. Shupenina, et al.
Published: (2022-12-01) -
Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case
by: A. A. Avagimyan, et al.
Published: (2021-11-01) -
Heart failure in cancer patients
by: A. F. Khalirakhmanov, et al.
Published: (2022-01-01) -
Cardioprotective effect of thiotriazoline in cancer patients
by: A. V. Koltsov, et al.
Published: (2023-02-01) -
Evaluation of cardiovascular comorbidity in cancer patients and analysis of potential risk factors for cardiovascular complications of checkpoint inhibitor therapy
by: E. A. Kushnareva, et al.
Published: (2022-01-01)